Wren Therapeutics raises £12.4m in latest financing round
Cambridge, UK-based biopharmaceutical company Wren Therapeutics has completed the closing of £12.4m financing, taking its total capital raised to date to around £33m. The latest
Roche’s faricimab hits primary endpoint in wet AMD studies
Roche’s investigational bispecific antibody faricimab has hit the primary endpoint in two Phase III studies in people living with neovascular or wet age-related macular degeneration
AbbVie’s Rinvoq bags two new EU approvals
The European Commission (EC) has approved AbbVie’s Rinvoq (upadacitinib) for the treatment of active psoriatic arthritis (PsA) and active ankylosing spondylitis (AS). The oral JAK
Moderna says its COVID-19 vaccine works effectively against variants
US-based Moderna has reported that its COVID-19 vaccine seems to work effectively against new variants of the coronavirus discovered in the UK and South Africa.
Moderna to test different booster shot against South Africa coronavirus variant
Moderna is weighing a second booster shot to battle back a new coronavirus variant, even as it affirms its current vaccine’s activity against newly emerging
Fierce Pharma Politics—Could a Senate drug pricing bill be ‘a positive’ for pharma? One analyst says so
Editor’s note: With the 2020 elections in the books and a new government in place, this will be the final edition of Fierce Pharma Politics. We’ll
Pfizer’s 6-dose-per-vial OK boosts its supply numbers. The catch? Special syringes are required
When pharmacists discovered a sixth dose could be pulled from vials of Pfizer and BioNTech’s vaccine, rather than the original five, it looked like a
Bristol Myers, Exelixis snag Opdivo-Cabometyx kidney cancer nod to challenge Merck, Pfizer
Bristol Myers Squibb snagged an FDA go-ahead to open another front in Opdivo’s rivalry with Merck & Co.’s Keytruda. The FDA approved the combination of
Civica Rx lays out $124M sterile injectables plant, pegged to supply COVID-19 drugs and more
Last spring, upstart generics maker Civica Rx joined forces with the brand-new Phlow Corp. in a push to “onshore” U.S. drug manufacturing and supply essential meds
PharmaTimes confirms INTCR 2021 virtual finals days
The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be conducted virtually. Last year’s competition was a